SS
Steven Seedhouse Raymond James Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Korro Bio
KRRO
$264M
| $28.09 | $147 |
423%
upside
| Strong Buy | 22 days ago |
|
2
Mirum Pharmaceuticals
MIRM
$3.73B
| $74.18 | $82 |
11%
upside
| Strong Buy | 28 days ago |
|
|
3
Korro Bio
KRRO
$264M
| $28.09 | $74 |
163%
upside
| Overweight | 4 months ago |
|
4
Wave Life Sciences
WVE
$1.3B
| $8.18 | $10 |
22%
upside
| Overweight | 4 months ago |
|
5
Pharvaris
PHVS
$1.41B
| $21.98 | $28 |
27%
upside
| Overweight | 4 months ago |
|
6
Astria Therapeutics
ATXS
$395M
| $7 | $47 |
571%
upside
| Overweight | 4 months ago |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.27 | $20 |
142%
upside
| Overweight | 4 months ago |
|
8
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $104 |
292%
upside
| Overweight | 4 months ago |
|
|
9
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $125 |
371%
upside
| Strong Buy | 7 months ago |
|
10
Dianthus Therapeutics
DNTH
$794M
| $24.66 | $56 |
127%
upside
| Outperform | 10 months ago |
|
11
89bio
ETNB
$1.28B
| $8.61 | $49 |
469%
upside
| Strong Buy | 10 months ago |
|
12
ProQR Therapeutics
PRQR
$252M
| $2.39 | $14 |
486%
upside
| Strong Buy | 10 months ago |
|
|
13
Wave Life Sciences
WVE
$1.3B
| $8.18 | $22 |
169%
upside
| Strong Buy | 10 months ago |
|
14
Gilead Sciences
GILD
$140B
| $112.77 | $93 |
18%
downside
| Outperform | 1 year ago |
|
15
Vera Therapeutics
VERA
$1.4B
| $21.90 | $68 |
211%
upside
| Strong Buy | 1 year ago |
|
16
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $106 |
270%
upside
| Strong Buy | 1 year ago |
|
17
Ardelyx
ARDX
$1.58B
| $6.57 | $15 |
128%
upside
| Strong Buy | 1 year ago |
|
18
Dyne Therapeutics
DYN
$1.88B
| $13.24 | $56 |
323%
upside
| Strong Buy | 1 year ago |
|
19
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $57 |
391%
upside
| Outperform | 1 year ago |
|
20
Rocket Pharmaceuticals
RCKT
$349M
| $3.23 | $35 |
984%
upside
| Outperform | 2 years ago |
|
21
Kymera Therapeutics
KYMR
$3.02B
| $42.20 | $38 |
10%
downside
| Outperform | 2 years ago |
|
22
Avidity Biosciences
RNA
$6.24B
| $48.47 | $71 |
46%
upside
| Strong Buy | 2 years ago |
|
23
Gossamer Bio
GOSS
$571M
| $2.51 | $5 |
99%
upside
| Outperform | 2 years ago |
|
24
AnaptysBio
ANAB
$590M
| $21.09 | $38 |
80%
upside
| Outperform | 2 years ago |
|